September 20, 2026

Layla Zulfa

A Movement of Resilience: How Black Women are Redefining Community and Care at the National Breast Cancer Foundation a-movement-of-resilience-how-black-women-are-redefining-community-and-care-at-the-national-breast-cancer-foundation

A Movement of Resilience: How Black Women are Redefining Community and Care at the National Breast Cancer Foundation

Layla Zulfa August 13, 2026
By Severina Ware, NBCF Director of Volunteer Services In the corridors of the National Breast Cancer Foundation...
Read More Read more about A Movement of Resilience: How Black Women are Redefining Community and Care at the National Breast Cancer Foundation
Divesiran Shows Promising Results in Polycythemia Vera Trial, Poised to Disrupt Established Market divesiran-shows-promising-results-in-polycythemia-vera-trial-poised-to-disrupt-established-market

Divesiran Shows Promising Results in Polycythemia Vera Trial, Poised to Disrupt Established Market

Layla Zulfa August 12, 2026
London, UK – [Insert Date] – British biotechnology firm Silence Therapeutics has sent ripples through the pharmaceutical...
Read More Read more about Divesiran Shows Promising Results in Polycythemia Vera Trial, Poised to Disrupt Established Market
Public Health at a Crossroads: White House Executive Order Seeks to Overhaul Childhood Vaccination Schedule Amid Measles Resurgence public-health-at-a-crossroads-white-house-executive-order-seeks-to-overhaul-childhood-vaccination-schedule-amid-measles-resurgence

Public Health at a Crossroads: White House Executive Order Seeks to Overhaul Childhood Vaccination Schedule Amid Measles Resurgence

Layla Zulfa August 12, 2026
By Editorial Staff The United States public health landscape is currently defined by a sharp, high-stakes collision...
Read More Read more about Public Health at a Crossroads: White House Executive Order Seeks to Overhaul Childhood Vaccination Schedule Amid Measles Resurgence
PepGen’s PGN-EDODM1 Advances to Highest Dose in Phase II DM1 Trial Amidst Strong Safety Profile pepgens-pgn-edodm1-advances-to-highest-dose-in-phase-ii-dm1-trial-amidst-strong-safety-profile

PepGen’s PGN-EDODM1 Advances to Highest Dose in Phase II DM1 Trial Amidst Strong Safety Profile

Layla Zulfa August 8, 2026
Boston, MA – [Insert Date] – PepGen Inc. (NASDAQ: PEPG), a clinical-stage biotechnology company focused on transforming...
Read More Read more about PepGen’s PGN-EDODM1 Advances to Highest Dose in Phase II DM1 Trial Amidst Strong Safety Profile

You may have missed

the-great-insurance-debate-dissecting-the-role-of-health-insurers-in-americas-fiscal-crisis

The Great Insurance Debate: Dissecting the Role of Health Insurers in America’s Fiscal Crisis

Muslim September 20, 2026
beyond-the-cream-how-a-fathers-quest-for-relief-sparked-a-skincare-revolution-2

Beyond the Cream: How a Father’s Quest for Relief Sparked a Skincare Revolution

Lina Hope September 20, 2026
salk-scientists-unveil-estrogen-related-receptors-as-key-to-unlocking-energy-metabolism-and-combating-muscle-fatigue

Salk Scientists Unveil Estrogen-Related Receptors as Key to Unlocking Energy Metabolism and Combating Muscle Fatigue

Ammar Sabilarrohman September 20, 2026
the-architecture-of-hope-mapping-the-centuries-long-evolution-of-breast-cancer-treatment

The Architecture of Hope: Mapping the Centuries-Long Evolution of Breast Cancer Treatment

Suro Senen September 20, 2026